Gwelodd Mr Gething drosto’i hun sut mae technoleg uwch yn darparu dull diagnostig moleciwlaidd i brofi samplau, gan gyflymu’r broses o gael canlyniadau gastroberfeddol a nodi marcwyr genetig sy’n gallu helpu i deilwra gofal i’r claf unigol. Dylai hyn olygu profion mwy cywir gyda chanlyniadau cyflymach, fydd yn gwella triniaeth i gleifion. Mae’r prosiect yn cael buddsoddiad o £2.5 miliwn dros gyfnod o dair blynedd i ariannu’r system newydd ar draws Cymru.
Mr Gething saw how high-tech molecular diagnostic equipment is being used to test samples, speeding up gastro-intestinal results and identifying genetic markers that help to better tailor care to the individual patient. This should mean more accurate testing with quicker results, improving treatment for patients. The project is receiving £2.5million investment over three years to fund the new system across Wales.